King's College London

Research portal

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

Research output: Contribution to journalLetter

The Secure-AD, PsoPROTECT study groups

Original languageEnglish
Pages (from-to)404-406
Number of pages3
JournalBritish Journal of Dermatology
Volume183
Issue number2
DOIs
Publication statusPublished - 1 Aug 2020

King's Authors

Abstract

We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454